This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Beckmann, M. L. Articles by Nies, A. S. Search for Related Content PubMed PubMed Citation Articles by Beckmann, M. L. Articles by Nies, A. S.

Hypertension, Vol 12, 582-588, Copyright © 1988 by American Heart Association

ARTICLES

Propranolol increases prostacyclin synthesis in patients with essential hypertension

ML Beckmann, JG Gerber, RL Byyny, M LoVerde and AS Nies
Department of Medicine, University of Colorado School of Medicine, Denver 80262.

We tested the hypothesis that vascular prostacyclin synthesis is increased by propranolol and could account for some of the drug's antihypertensive effect. We studied 10 white patients with mild essential hypertension in a randomized, double-blind design to assess the effects of indomethacin with or without the addition of propranolol on blood pressure and vascular prostacyclin biosynthesis, as assessed by the urinary excretion of the major enzymatically produced metabolite of prostacyclin, 2,3-dinor-6-keto-prostaglandin F1 alpha (PGF1 alpha), F1 alpha (PGF1 alpha), measured by gas chromatography-mass spectrometry. Seven patients responded to propranolol with a lowering of mean arterial blood pressure in both supine and upright postures. The fall in mean arterial blood pressure (-14.1 +/- 2.1 mm Hg sitting; - 17.4 +/- 1.7 mm Hg supine) with propranolol alone was significantly greater than that produced when propranolol was given to patients receiving indomethacin (-7.8 +/- 1.9 mm Hg sitting; -7.7 +/- 3.0 mm Hg supine). Our drug-responsive patients demonstrated a significantly lower excretion rate of 2,3-dinor-6-keto-PGF1 alpha than was found in an age and sex-matched group of normal volunteers. With propranolol treatment, drug-responsive patients showed a significant increase in the excretion of 2,3-dinor-6-keto-PGF1 alpha, such that the mean excretion was not significantly different from that in normal volunteers. Indomethacin caused a significant rise in mean arterial blood pressure and a significant fall in 2,3-dinor-6-keto-PGF1 alpha excretion, and it blocked the rise in urinary 2,3-dinor-6-keto-PGF1 alpha associated with propranolol therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				P. R. Conlin, T. J. Moore, S. L. Swartz, E. Barr, L. Gazdick, C. Fletcher, P. DeLucca, and L. Demopoulos Effect of Indomethacin on Blood Pressure Lowering by Captopril and Losartan in Hypertensive Patients Hypertension, September 1, 2000; 36(3): 461 - 465. [Abstract] [Full Text] [PDF]

				M. R. Marino, K. M. Langenbacher, N. F. Ford, R. H. Raymond, J. Manning, O. Vesterqvist, E. Cooper Shamblen, and K. C. Lasseter Pharmacodynamics and Pharmacokinetics of Irbesartan in Patients With Mild to Moderate Hypertension Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(2): 67 - 75. [Abstract] [PDF]

				B. W. Griffin, G. W. Williams, J. Y. Crider, and N. A. Sharif FP Prostaglandin Receptors Mediating Inositol Phosphates Generation and Calcium Mobilization in Swiss 3T3 Cells: A Pharmacological Study J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 845 - 854. [Abstract] [Full Text]

				J. E. Pope, J. J. Anderson, and D. T. Felson A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure Arch Intern Med, February 22, 1993; 153(4): 477 - 484. [Abstract] [PDF]

				T. Kato, S. Yoneda, M. Koketsu, and T. Fujinami Effects of Prostacyclin Infusion on Blood Pressure and Plasma Renin Activity in Patients with Essential Hypertension Angiology, February 1, 1992; 43(2): 110 - 120. [Abstract] [PDF]